Heartbeam End Period Cash Flow vs Change To Liabilities Analysis

BEAT Stock

USD 3.06 0.21 7.37%

Heartbeam financial indicator trend analysis is much more than just examining Heartbeam latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Heartbeam is a good investment. Please check the relationship between Heartbeam End Period Cash Flow and its Change To Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Heartbeam. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.

End Period Cash Flow vs Change To Liabilities

End Period Cash Flow vs Change To Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Heartbeam End Period Cash Flow account and Change To Liabilities. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Heartbeam's End Period Cash Flow and Change To Liabilities is -0.16. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Change To Liabilities in the same time period over historical financial statements of Heartbeam, assuming nothing else is changed. The correlation between historical values of Heartbeam's End Period Cash Flow and Change To Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Heartbeam are associated (or correlated) with its Change To Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Liabilities has no effect on the direction of End Period Cash Flow i.e., Heartbeam's End Period Cash Flow and Change To Liabilities go up and down completely randomly.

Correlation Coefficient

-0.16

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Change To Liabilities

Most indicators from Heartbeam's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Heartbeam current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Heartbeam. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.At this time, Heartbeam's Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.32 in 2024, whereas Selling General Administrative is likely to drop slightly above 8.1 M in 2024.

	2023	2024 (projected)
Other Operating Expenses	15.3M	14.5M
Gross Profit	315.4M	331.2M

Other Operating Expenses Gross Profit

Heartbeam fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Other Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Good Will	Intangible Assets
Total Assets		0.99	0.92	0.89	-0.15	0.82	0.71	0.82	0.99	0.92	0.96	0.9	0.84	0.68	-0.41	0.84	0.67	0.03	-0.3	0.97	0.92	-0.12	-0.13	0.79	-0.08	0.12
Total Stockholder Equity	0.99		0.85	0.91	-0.18	0.86	0.78	0.87	0.95	0.95	0.91	0.89	0.83	0.66	-0.48	0.88	0.62	0.0	-0.36	0.93	0.9	-0.17	-0.16	0.83	-0.17	0.03
Net Debt	0.92	0.85		0.69	-0.11	0.59	0.46	0.6	0.96	0.7	0.97	0.8	0.71	0.66	-0.16	0.63	0.74	0.14	-0.08	0.98	0.88	-0.06	-0.09	0.62	0.17	0.37
Cash	0.89	0.91	0.69		-0.13	0.94	0.73	0.75	0.84	0.93	0.81	0.72	0.72	0.5	-0.39	0.8	0.48	-0.09	-0.25	0.83	0.69	-0.07	-0.11	0.62	-0.08	0.07
Other Assets	-0.15	-0.18	-0.11	-0.13		-0.15	-0.46	-0.28	-0.11	-0.2	-0.02	-0.1	0.24	-0.23	0.08	-0.17	-0.17	-0.09	-0.35	-0.11	-0.17	0.96	1.0	-0.16	-0.26	-0.34
Cash And Short Term Investments	0.82	0.86	0.59	0.94	-0.15		0.73	0.76	0.75	0.95	0.72	0.69	0.65	0.45	-0.44	0.72	0.4	-0.1	-0.31	0.73	0.62	-0.11	-0.13	0.55	-0.18	-0.04
Common Stock Shares Outstanding	0.71	0.78	0.46	0.73	-0.46	0.73		0.92	0.63	0.84	0.51	0.77	0.63	0.51	-0.76	0.85	0.31	-0.12	-0.44	0.56	0.68	-0.51	-0.43	0.83	-0.39	-0.22
Other Stockholder Equity	0.82	0.87	0.6	0.75	-0.28	0.76	0.92		0.75	0.91	0.65	0.91	0.81	0.61	-0.83	0.93	0.41	-0.09	-0.64	0.68	0.81	-0.36	-0.25	0.92	-0.53	-0.34
Total Liab	0.99	0.95	0.96	0.84	-0.11	0.75	0.63	0.75		0.85	0.99	0.88	0.82	0.67	-0.33	0.79	0.7	0.06	-0.24	0.99	0.91	-0.07	-0.09	0.73	0.01	0.21
Total Current Assets	0.92	0.95	0.7	0.93	-0.2	0.95	0.84	0.91	0.85		0.79	0.86	0.8	0.6	-0.6	0.88	0.5	-0.06	-0.45	0.81	0.78	-0.2	-0.18	0.77	-0.31	-0.13
Short Long Term Debt Total	0.96	0.91	0.97	0.81	-0.02	0.72	0.51	0.65	0.99	0.79		0.82	0.78	0.62	-0.21	0.7	0.69	0.07	-0.16	1.0	0.87	0.04	0.0	0.64	0.1	0.29
Other Current Liab	0.9	0.89	0.8	0.72	-0.1	0.69	0.77	0.91	0.88	0.86	0.82		0.92	0.64	-0.69	0.91	0.53	-0.04	-0.56	0.83	0.92	-0.16	-0.08	0.9	-0.38	-0.17
Total Current Liabilities	0.84	0.83	0.71	0.72	0.24	0.65	0.63	0.81	0.82	0.8	0.78	0.92		0.55	-0.65	0.89	0.45	-0.08	-0.69	0.77	0.81	0.18	0.26	0.85	-0.49	-0.32
Property Plant And Equipment Net	0.68	0.66	0.66	0.5	-0.23	0.45	0.51	0.61	0.67	0.6	0.62	0.64	0.55		-0.34	0.63	0.94	0.71	-0.27	0.66	0.62	-0.34	-0.22	0.62	-0.13	0.02
Retained Earnings	-0.41	-0.48	-0.16	-0.39	0.08	-0.44	-0.76	-0.83	-0.33	-0.6	-0.21	-0.69	-0.65	-0.34		-0.73	-0.03	0.21	0.86	-0.24	-0.47	0.25	0.06	-0.75	0.85	0.74
Accounts Payable	0.84	0.88	0.63	0.8	-0.17	0.72	0.85	0.93	0.79	0.88	0.7	0.91	0.89	0.63	-0.73		0.47	-0.03	-0.6	0.72	0.79	-0.22	-0.14	0.92	-0.47	-0.29
Non Current Assets Total	0.67	0.62	0.74	0.48	-0.17	0.4	0.31	0.41	0.7	0.5	0.69	0.53	0.45	0.94	-0.03	0.47		0.75	0.0	0.71	0.59	-0.21	-0.16	0.44	0.17	0.31
Non Currrent Assets Other	0.03	0.0	0.14	-0.09	-0.09	-0.1	-0.12	-0.09	0.06	-0.06	0.07	-0.04	-0.08	0.71	0.21	-0.03	0.75		0.14	0.08	-0.01	-0.21	-0.11	-0.04	0.16	0.17
Net Receivables	-0.3	-0.36	-0.08	-0.25	-0.35	-0.31	-0.44	-0.64	-0.24	-0.45	-0.16	-0.56	-0.69	-0.27	0.86	-0.6	0.0	0.14		-0.14	-0.35	-0.17	-0.37	-0.64	0.96	0.89
Non Current Liabilities Total	0.97	0.93	0.98	0.83	-0.11	0.73	0.56	0.68	0.99	0.81	1.0	0.83	0.77	0.66	-0.24	0.72	0.71	0.08	-0.14		0.88	-0.05	-0.09	0.66	0.1	0.3
Other Current Assets	0.92	0.9	0.88	0.69	-0.17	0.62	0.68	0.81	0.91	0.78	0.87	0.92	0.81	0.62	-0.47	0.79	0.59	-0.01	-0.35	0.88		-0.19	-0.15	0.85	-0.14	0.08
Short Term Debt	-0.12	-0.17	-0.06	-0.07	0.96	-0.11	-0.51	-0.36	-0.07	-0.2	0.04	-0.16	0.18	-0.34	0.25	-0.22	-0.21	-0.21	-0.17	-0.05	-0.19		0.96	-0.25	-0.07	-0.15
Common Stock	-0.13	-0.16	-0.09	-0.11	1.0	-0.13	-0.43	-0.25	-0.09	-0.18	0.0	-0.08	0.26	-0.22	0.06	-0.14	-0.16	-0.11	-0.37	-0.09	-0.15	0.96		-0.14	-0.28	-0.36
Current Deferred Revenue	0.79	0.83	0.62	0.62	-0.16	0.55	0.83	0.92	0.73	0.77	0.64	0.9	0.85	0.62	-0.75	0.92	0.44	-0.04	-0.64	0.66	0.85	-0.25	-0.14		-0.51	-0.32
Good Will	-0.08	-0.17	0.17	-0.08	-0.26	-0.18	-0.39	-0.53	0.01	-0.31	0.1	-0.38	-0.49	-0.13	0.85	-0.47	0.17	0.16	0.96	0.1	-0.14	-0.07	-0.28	-0.51		0.98
Intangible Assets	0.12	0.03	0.37	0.07	-0.34	-0.04	-0.22	-0.34	0.21	-0.13	0.29	-0.17	-0.32	0.02	0.74	-0.29	0.31	0.17	0.89	0.3	0.08	-0.15	-0.36	-0.32	0.98

Click cells to compare fundamentals

Heartbeam Account Relationship Matchups

Heartbeam fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7K	51K	14.0M	4.0M	17.1M	16.3M
Total Stockholder Equity	(3.7M)	(4.8M)	13.4M	2.4M	15.9M	15.1M
Net Debt	3.4M	4.3M	(13.2M)	(3.6M)	(16.2M)	(15.4M)
Cash	5K	24K	13.2M	3.6M	16.2M	17.4M
Cash And Short Term Investments	5K	24K	13.2M	3.6M	16.2M	19.6M
Liabilities And Stockholders Equity	7K	51K	14.0M	4.0M	17.1M	16.3M
Other Stockholder Equity	1K	11K	22.6M	24.6M	52.8M	50.1M
Total Liab	3.7M	4.8M	588K	1.7M	1.2M	1.1M
Total Current Assets	7K	51K	14.0M	4.0M	16.8M	16.0M
Short Long Term Debt Total	199.4M	198.5M	3.4M	4.3M	4.9M	4.7M
Other Current Liab	312K	540.5K	587.4K	1.7M	1.2M	1.1M
Total Current Liabilities	354K	4.8M	588K	1.7M	1.2M	1.1M
Property Plant And Equipment Net	49.2M	48.4M	56.4M	0.0	256K	243.2K
Retained Earnings	(3.7M)	(4.8M)	(9.2M)	(22.2M)	(36.8M)	(38.7M)
Accounts Payable	310.0	474.0	587.0	1.7K	1.2K	1.1K
Non Current Assets Total	434.5M	440.1M	517.4M	0.0	306K	290.7K
Non Currrent Assets Other	2.8M	3.3M	17.5M	50K	57.5K	54.6K
Other Current Assets	2K	27K	806K	445K	636K	604.2K
Short Term Debt	2.1M	5.1M	42K	4.3M	3.9M	3.4M
Current Deferred Revenue	4.3M	3.1M	(310.0)	(474.0)	(545.1)	(517.84)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Heartbeam Stock Analysis

When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC